object
determin
immun
phenotyp
associ
immunosenesc
predict
risk
respiratori
viral
infect
elderli
nurs
home
resid
method
resid
year
nurs
home
canadian
citi
enrol
fall
follow
one
influenza
season
follow
influenza
vaccin
peripher
blood
mononuclear
cell
pbmc
obtain
analys
flow
cytometri
treg
tcell
subset
cmvreactiv
tcell
nasopharyng
swab
obtain
test
virus
symptomat
resid
cox
proport
hazard
model
adjust
age
sex
frailti
determin
relationship
immun
phenotyp
time
viral
infect
result
resid
enrol
median
age
year
femal
swab
obtain
posit
viru
influenza
rsv
coronaviru
rhinoviru
human
metapneumoviru
parainfluenza
multivari
analysi
high
treg
hr
ci
high
cmvreactiv
tcell
hr
ci
predict
respiratori
viral
infect
elderli
nurs
home
resid
high
cmvreactiv
tcell
associ
increas
risk
high
treg
associ
reduc
risk
respiratori
viral
infect
burden
respiratori
viral
infect
elderli
nurs
home
resid
high
activ
surveil
incid
respiratori
viral
infect
estim
rang
per
resid
day
influenza
respiratori
syncyti
viru
rsv
virus
commonli
respons
morbid
mortal
associ
infect
respiratori
virus
includ
parainfluenza
human
metapneumoviru
coronaviru
rhinoviru
also
caus
sever
diseas
popul
wide
held
belief
immunosenesc
wane
immun
function
associ
old
age
respons
increas
risk
sever
infect
howev
spars
data
exist
substanti
posit
first
step
toward
identif
immun
biomark
predict
respiratori
viral
infect
elderli
nurs
home
resid
character
immun
phenotyp
elderli
nurs
home
resid
whole
blood
analysi
circul
tcell
subset
perform
crosssect
studi
involv
nurs
home
elderli
particip
immun
phenotyp
compar
immun
phenotyp
healthi
adult
addit
explor
individu
immun
phenotyp
influenc
age
sex
frailti
nutrit
statu
nurs
home
elderli
observ
lower
tcell
higher
termin
differenti
memori
tcell
senesc
tcell
compar
healthi
adult
consist
prior
find
elderli
peopl
hypothes
reduc
number
tcell
observ
elderli
due
thymic
involut
coupl
accumul
poorli
function
termin
differenti
memori
tcell
senesc
cell
possibl
aris
chronic
antigen
stimul
cytomegaloviru
cmv
predispos
elderli
peopl
infect
support
hypothesi
senesc
tcell
high
titr
cmv
antibodi
found
associ
influenza
vaccin
failur
older
peopl
whether
tcell
subset
associ
infect
less
clear
accumul
separ
class
tcell
regulatori
tcell
treg
elderli
peopl
also
observ
elderli
nurs
home
resid
commun
dwell
elderli
peopl
treg
known
respons
control
magnitud
tcell
respons
viral
infect
whether
accumul
treg
elderli
lead
impair
host
control
infect
known
knowledg
relationship
immun
phenotyp
associ
immunosenesc
risk
respiratori
viral
infect
studi
relationship
establish
could
help
identifi
elderli
nurs
home
resid
highest
risk
becom
ill
could
provid
focus
care
target
prevent
end
sought
identifi
immun
biomark
predict
respiratori
viral
infect
ensu
respiratori
viral
season
elderli
nurs
home
cohort
prospect
cohort
studi
elderli
particip
recruit
nurs
home
canadian
citi
halifax
nova
scotia
sherbrook
quebec
hamilton
ontario
vancouv
british
columbia
septemb
octob
resid
recruit
separ
studi
also
elig
inclus
studi
resid
year
age
elig
studi
exclus
criteria
includ
individu
plan
vaccin
influenza
receiv
immunosuppress
medic
includ
cancer
chemotherapi
oral
corticosteroid
use
day
methotrex
posttranspl
medic
andor
anticytokin
blymphocyt
deplet
therapi
expect
die
within
day
determin
supervis
physician
written
inform
consent
obtain
particip
legal
appoint
guardian
event
compet
provid
consent
studi
protocol
approv
research
ethic
board
particip
institut
nurs
home
train
research
personnel
abstract
baselin
demograph
particip
base
interview
examin
chart
review
frailti
rate
accord
clinic
frailti
scale
scale
rang
follow
fit
well
well
treat
comorbid
ill
appar
vulner
mildli
frail
defin
depend
instrument
activ
daili
live
adl
moder
frail
defin
requir
assist
basic
adl
sever
frail
defin
complet
depend
other
adl
sever
frail
clinic
frailti
scale
valid
nurs
home
popul
particip
receiv
season
influenza
vaccin
typic
octob
novemb
public
health
nurs
accord
guidelin
recommend
given
year
peripher
blood
mononuclear
cell
pbmc
drawn
particip
day
post
vaccin
resid
activ
follow
research
staff
influenza
season
immedi
follow
pbmc
draw
influenza
season
defin
span
first
week
specimen
submit
local
public
health
laboratori
viral
test
posit
influenza
end
posit
influenza
consecut
week
influenza
season
chosen
period
followup
rate
respiratori
viral
infect
highest
winter
month
train
research
personnel
review
particip
presenc
symptom
sign
respiratori
ill
twice
weekli
often
notifi
symptom
nurs
home
staff
nasopharyng
swab
copan
eswab
copan
diagnost
inc
murrieta
california
obtain
research
staff
resid
one
follow
new
symptom
sign
fever
worsen
cough
nasal
congest
sore
throat
headach
sinu
problem
muscl
ach
fatigu
ear
ach
infect
chill
otherwis
explain
altern
diagnosi
blood
obtain
particip
hour
hand
deliv
research
laboratori
immedi
process
pbmc
isol
frozen
use
valid
common
standard
oper
procedur
tcell
immun
phenotyp
determin
thaw
patient
pbmc
previous
describ
viabil
pbmc
found
rang
averag
viabil
aliquot
cellsstain
place
roundbottom
plate
flour
blue
texa
red
treg
identifi
use
blue
follow
antibodi
purchas
bd
bioscienc
blue
follow
antibodi
purchas
ebiosci
purchas
invitrogen
antibodi
purchas
beckman
coulter
defin
tcell
subset
follow
termin
differenti
senesc
treg
defin
hi
lo
immun
phenotyp
treg
express
percentag
antibodi
stain
perform
use
beckman
coulter
biomek
nx
p
laboratori
autom
workstat
beckman
coulter
ontario
previous
describ
follow
analysi
use
lsr
ii
flow
cytomet
highthroughput
sampler
bd
bioscienc
nj
usa
treg
analyz
use
flowjo
treestar
inc
ashland
tcell
subset
analysi
employ
autom
gate
pipelin
use
flowdens
algorithm
approach
use
custom
threshold
calcul
differ
cell
subset
mimic
manual
gate
scheme
base
expert
knowledg
hierarch
gate
order
densiti
inform
popul
identif
individu
tune
cell
popul
data
driven
manner
tcell
subpopul
identifi
use
characterist
densiti
distribut
number
peak
height
width
peak
chang
slope
distribut
curv
standard
deviat
median
densiti
figur
threshold
estim
base
control
sampl
appli
automat
stimul
sampl
threshold
estim
base
popul
given
explicit
instruct
cell
figur
total
popul
identifi
approach
use
high
perform
comput
resourc
michael
smith
genom
scienc
centr
order
reduc
comput
time
cmvreactiv
tcell
identifi
stimul
pbmc
pool
overlap
peptid
span
immunodomin
protein
cmv
peptiv
miltenyi
biotec
accord
publish
protocol
briefli
thaw
pbmc
cultur
overnight
stimul
cmv
peptid
ugml
hr
match
set
pbmc
stimul
dmso
neg
control
brefeldin
bd
bioscienc
ad
accord
manufactur
instruct
cell
incub
addit
hour
cell
stain
permeabil
final
stain
antiifncapc
antitnfafitc
cmvreactiv
tcell
identifi
ifnc
tnfa
use
ul
nasopharyng
swab
materi
nucleic
acid
extract
biomerieux
easymag
autom
extractor
specimen
test
use
xtag
respiratori
viru
panel
rvp
assay
influenza
subtyp
influenza
b
rsv
subtyp
b
parainfluenza
coronaviru
human
metapneumoviru
enterorhinoviru
adenoviru
per
manufactur
protocol
luminex
molecular
diagnost
inc
toronto
ontario
immun
phenotyp
distribut
well
age
distribut
skew
distribut
continu
variabl
summar
median
interquartil
rang
iqr
age
sex
pbmc
obtain
compar
use
mannwhitney
u
chisquar
test
appropri
complet
case
analysi
immun
phenotyp
plan
miss
data
paramet
unadjust
hazard
ratio
hr
confid
interv
ci
use
cox
proport
hazard
model
first
construct
explor
relationship
immun
phenotyp
time
symptomat
respiratori
viral
infect
event
resid
multipl
respiratori
viral
infect
first
infect
includ
outcom
particip
die
prior
respiratori
viral
infect
time
censor
date
death
hypothes
follow
immun
phenotyp
associ
immunosenesc
would
associ
increas
risk
infect
low
tcell
high
termin
differenti
senesc
tcell
well
high
cmvreactiv
tcell
high
treg
low
defin
immun
phenotyp
first
quartil
distribut
high
defin
immun
phenotyp
fourth
quartil
distribut
priori
decid
age
sex
frailti
would
includ
final
model
given
potenti
confound
effect
primari
interest
popul
immun
phenotyp
pvalu
univari
analysi
includ
final
multivari
model
final
model
determin
use
backward
elimin
sandwich
varianc
estim
use
account
cluster
effect
level
nurs
home
proport
hazard
assumpt
continu
variabl
explor
graphic
plot
partial
residu
time
event
test
regress
partial
residu
time
proport
hazard
assumpt
categor
variabl
examin
logminuslog
graph
ensur
plot
line
remain
parallel
presenc
multicollinear
examin
use
varianc
inflat
factor
vif
presenc
multicollinear
defin
vif
pvalu
ci
construct
use
test
pvalu
consid
statist
signific
statist
analys
perform
use
r
version
total
resid
enrol
studi
pbmc
obtain
reason
obtain
pbmc
either
refus
influenza
vaccin
refus
blood
draw
statist
signific
differ
age
median
iqr
versu
iqr
without
pbmc
p
sex
femal
versu
without
pbmc
p
pbmc
obtain
fifteen
particip
withdrew
end
studi
leav
final
sampl
size
seventythre
particip
die
respiratori
viral
infect
could
identifi
baselin
characterist
final
cohort
summar
tabl
median
age
year
iqr
year
age
rang
year
eight
person
year
least
one
comorbid
almost
half
score
either
clinic
frailti
scale
defin
sever
sever
frail
respect
figur
describ
gate
strategi
use
defin
immun
phenotyp
median
correspond
iqr
immun
cell
type
test
studi
found
tabl
total
swab
obtain
symptomat
peopl
nasopharyng
swab
posit
virus
symptomat
resid
tabl
coronaviru
influenza
rhinoviru
rsv
common
virus
found
one
nasopharyng
swab
posit
influenza
also
rhinoviru
present
subsequ
investig
whether
relationship
exist
specif
immun
cell
popul
respiratori
viru
infect
proport
hazard
assumpt
satisfi
covari
includ
model
concern
evid
multicollinear
vif
univari
analys
low
tcell
hr
ci
high
treg
hr
ci
associ
reduc
risk
respiratori
viral
infect
high
termin
differenti
tcell
hr
ci
high
senesc
tcell
hr
ci
high
cmvreactiv
tcell
hr
ci
associ
increas
risk
respiratori
viral
infect
tabl
multivari
analysi
adjust
age
sex
frailti
high
treg
hr
ci
high
cmvreactiv
tcell
hr
ci
remain
predict
respiratori
viral
infect
final
model
tabl
figur
prospect
cohort
studi
elderli
nurs
home
resid
cell
particular
treg
cmvreactiv
tcell
predict
respiratori
viral
infect
ensu
respiratori
viral
season
multivari
analysi
contrast
tcell
found
predict
multivari
analysi
knowledg
first
studi
identifi
immun
biomark
predict
respiratori
viral
infect
elderli
peopl
treg
respons
creat
balanc
immun
respons
pathogen
harm
sequela
inflamm
aris
respons
high
treg
consist
observ
elderli
peopl
compar
healthi
adult
hypothes
shift
may
associ
increas
risk
infect
seen
elderli
intrigu
studi
higher
level
circul
treg
associ
reduc
risk
symptomat
respiratori
viru
infect
systemat
test
resid
studi
respiratori
viru
throughout
studi
determin
whether
associ
high
treg
reduc
risk
infect
due
absenc
infect
whether
higher
incid
asymptomat
infect
high
treg
group
littl
known
role
treg
prevent
acut
respiratori
viral
infect
human
mice
robust
treg
respons
observ
influenza
rsv
infect
deplet
treg
delay
rsv
viral
clearanc
lung
suggest
treg
play
import
role
control
immun
respons
respiratori
consider
murin
data
specul
elev
level
treg
may
suppress
immun
patholog
associ
antivir
immun
cmv
propos
chronic
antigen
stimulu
respons
acceler
immunosenesc
includ
accumul
senesc
tcell
least
three
studi
look
associ
cmv
infect
influenza
vaccin
respons
elderli
one
cmv
associ
influenza
vaccin
nonrespons
howev
two
studi
found
associ
contrast
report
seroposit
focus
tcell
respons
cmv
observ
elev
frequenc
cmvreactiv
tcell
cmvreactiv
tcell
associ
increas
risk
respiratori
viral
infect
unawar
studi
link
cmvreactiv
tcell
increas
risk
respiratori
viral
infect
difficult
specul
possibl
biolog
relationship
cmvreactiv
cell
suscept
infect
given
observ
treg
also
correl
suscept
interpret
collect
data
indic
distribut
function
cell
ie
effector
suppressor
within
cell
compart
strong
influenc
host
resist
elderli
research
date
focus
tcell
elderli
observ
strongli
support
new
line
research
elderli
understand
skew
tcell
compart
contribut
significantli
outcom
respiratori
infect
low
tcell
high
termin
differenti
tcell
senesc
tcell
describ
elderli
popul
hypothes
predict
risk
infect
although
associ
immun
phenotyp
risk
respiratori
viral
infect
univari
analys
adjust
known
confound
cell
phenotyp
defin
use
flowdens
softwar
packag
lymphocyt
first
gate
nonmargin
event
singlet
gate
threshold
calcul
base
singlet
lymphocyt
fmo
cell
gate
separ
express
analyz
either
age
sex
frailti
cell
predict
respiratori
viral
infect
immun
phenotyp
suspect
associ
respiratori
viral
infect
includ
model
illustr
need
robust
statist
approach
includ
adequ
sampl
size
allow
adjust
known
confound
immun
phenotyp
explor
associ
immun
biomark
outcom
frailti
state
variabl
aim
captur
person
vulner
advers
health
outcom
clinic
frailti
scale
use
previous
valid
nurs
home
resid
shown
robustli
predict
outcom
includ
mortal
disabl
cognit
declin
frailti
influenc
health
outcom
number
mechan
includ
overal
burden
diseasecomorbid
reduc
reserv
toler
insult
frailti
also
associ
immunosenesc
import
measur
overal
health
relev
immun
function
relev
measur
includ
studi
analysi
greatli
facilit
autom
analysi
approach
elimin
would
otherwis
extrem
timeconsum
process
manual
gate
fc
file
use
approach
unbias
rel
manual
gate
variabl
low
even
lower
manual
gate
approach
help
facilit
effici
futur
larg
studi
immun
biomark
studi
provid
insight
role
immunosenesc
risk
respiratori
viral
infect
elderli
nurs
home
resid
although
studi
design
identifi
associ
causat
find
suggest
possibl
strategi
boost
circul
treg
vaccin
prevent
infect
cmv
prophylact
antivir
therapi
prevent
reactiv
cmv
may
reduc
respiratori
viral
infect
highrisk
popul
addit
identifi
increas
risk
respiratori
viral
infect
could
offer
altern
prevent
strategi
heighten
surveil
highest
risk
period
could
help
prevent
nurs
home
outbreak
transmiss
healthcar
worker
famili
limit
studi
includ
lower
expect
influenza
viral
infect
although
influenza
necessarili
common
viru
isol
nurs
home
expect
see
case
resid
influenza
season
base
prior
respiratori
viral
infect
surveil
studi
conduct
nurs
home
believ
case
miss
inde
perform
prospect
activ
surveil
symptomat
respiratori
viral
infect
approxim
one
third
nasopharyng
swab
posit
viru
compar
anoth
studi
perform
activ
surveil
respiratori
infect
nurs
home
canada
instead
believ
lower
number
due
circul
pandem
influenza
strain
less
impact
older
peopl
influenza
season
prepandem
year
rel
low
incid
influenza
influenza
season
addit
lower
number
could
due
fact
includ
resid
vaccin
influenza
felt
influenza
vaccin
statu
import
confound
manag
statist
potenti
abil
prevent
influenza
infect
associ
healthi
user
bia
remain
possibl
differ
immun
predictor
differ
respiratori
virus
vaccin
cohort
combin
respiratori
virus
togeth
one
combin
endpoint
limit
generaliz
howev
chose
priori
combin
respiratori
virus
togeth
combin
endpoint
base
fact
result
similar
outcom
popul
low
number
particip
influenza
preclud
abil
perform
sensit
analysi
look
immun
phenotyp
predict
influenza
infect
addit
limit
unabl
includ
immun
phenotyp
continu
variabl
analysi
gener
maintain
data
continu
prefer
categor
data
howev
analysi
includ
immun
phenotyp
data
continu
feasibl
led
estim
wide
confid
interv
thu
analysi
perform
use
categor
variabl
similar
age
studi
although
seventythre
particip
die
prior
develop
respiratori
viral
infect
believ
compet
risk
introduc
signific
bia
compet
risk
unlik
bia
result
followup
short
proport
particip
experienc
compet
risk
less
proport
particip
experienc
outcom
studi
followup
short
one
influenza
season
proport
particip
die
less
develop
respiratori
viral
infect
last
result
obtain
frail
elderli
popul
may
generaliz
commun
dwell
elderli
conclus
elderli
nurs
home
resid
high
cmvreactiv
tcell
predict
increas
risk
respiratori
viral
infect
high
treg
predict
reduc
risk
ensu
respiratori
viral
season
find
provid
insight
immunosenesc
risk
infect
may
help
guid
futur
prevent
strategi
figur
comparison
autom
versu
manual
gate
tcell
phenotyp
gate
hierarchi
use
manual
top
row
autom
bottom
row
approach
tcell
panel
describ
text
similar
result
obtain
method
tiff
